The presence of methylation of the p16INK4A gene and human papillomavirus in high-grade cervical squamous intraepithelial lesions

Diagnostic Molecular Pathology

Volumn 19, Issue 1, 2010, Pages 15-19

  Furtado, Yara L ^a   Almeida, Gutemberg ^a   Lattario, Fernanda ^b   Silva, Katia S ^c   Maldonado, Paula ^a   Silveira, Filomena A ^a   Do Val, Isabel C ^a   Fonseca, Renata ^a   Da Gloria Carvalho, Maria ^b  

^a Gynecology Institute   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Genes; Human papillomavirus; Methylation; P16

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ARTICLE; CASE CONTROL STUDY; CHEMICAL MODIFICATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA METHYLATION; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA; DNA METHYLATION; DNA PRIMERS; DNA, VIRAL; FEMALE; GENES, P16; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77749334762     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3181aa8f64     Document Type: Article

References (32)

1. Parkin DM, Weln SL, Ferlay J, et al. Cancer InciDence in 5 Continents IARC Scientific Publication 155. Lyon, France: International Agency for Research on Cancer; 2002:8.
2. Bosch FX, Sanjosé S. Chapter 1-Human papillomavirus and cervical cancer: burDen and assessment of causality. J Natl Cancer Inst Monogr. 2003;31:3-13.
3. Acladious NN, Sutton C, Mandal D, et al. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int J Cancer. 2002;98:435-439.
4. Castellsagué X, Munoz N. Chapter 3- Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20-28.
5. Nuovo GJ, Plaia TW, Belinsky SA, et al. In situ Detection of the hypermetylation-induced inactivation of p16 gene as an early event in oncogenesis. PNAS. 1999;96:12754-12759.
6. Dong SM, Kim HS, Rha SH, et al. Promoter Hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res. 2001;7:1982-1986.
7. Terra APS, Murta EFC, Maluf PJ, et al. Aberrant promoter methylation can be useful as a marker of recorrent disease in patients with cervical intraepithelial neoplasia graDe III. Tumori. 2007;93:572-579.
8. Lea JS, Coleman R, Kurien A, et al. Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis. Am J Obstet Gynecol. 2004;190:674-679.
9. Tsuda H, Hashiguchi Y, Nishimura S, et al. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm. Gynecol Oncol. 2003;91:476-485.
10. Yang HJ, Liu VWS, Wang Y, et al. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol Oncol. 2004;93:435-440. (Pubitemid 38507614)
11. StrathDee G, Brown R. Epigenetic cancer therapies: DNA methytransferase inhibitors. Expert Opin Investig Drugs. 2002;11:747-754.
12. Miracca EC, Zeidler SVV, Birman EG, et al. Hypermethilation of the p16 gene in normal oral mucosa of smokers. Int J Mol Medicine. 2004;14:807-811.
13. Wong YF, Chung TKH, Cheung TH, et al. Methylation of p16INK4a in primary gynecologic malignancy. Cancer Lett. 1999; 136:231-235.
14. Esteller M. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair gene. Euro J Cancer. 2000;36:2294-2300.
15. Sano T, Oyama T, Kashiwabara K, et al. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int. 1998;48:580-585.
16. Cho NH, Kim YT, Kim JW. Alteration of cell cycle in cervical tumor associated with human papillomavirus-cyclin-DepenDent kinase inhibitors. Yonsei Med J. 2002;43:722-728.
17. Guimarã es MCM, Gonçalves MAG, Soares CP, et al. Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions. J Histochem Cytochem. 2005;53:509-516.
18. Eleutério JE Jr, Giraldo PC, Gonçalves AK, et al. Prognostic markers of high-graDe squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus. Acta Obstetricia et Gynecologica. 2007;86:94-98.
19. Murphy N, Ring M, Killalea AG, et al. P16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol. 2003;56:56-63.
20. Pestaner C, Bibbo M, Bobroski L, et al. Potential of the in situ polymerase chain reaction in diagnostic cytology. Acta Cytol. 1994;38:676.
21. Remmerbach TW, Brinckmann UG, Hemprich A, et al. PCR Detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/GP6+ primer sets. J Clin Virol. 2004;30:302-308.
22. Herman JG, Graff JR, Myö hänen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad. 1996;93:9821-9826.
23. Rosas SLB, Caballero OL, Dong SM, et al. Methylation status in the promoter region of human PGP 9.5 gene in cancer and normal tissues. Cancer Lett. 2001;170:73-79.
24. Wong YF, Chung TKH, Cheung TH, et al. p16INK4aand p15INK4b alterations in primary gynecologic malignancy. Gynecol Oncol. 1997;65:319-324.
25. Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429: 457-463.
26. Feng Q, Balasubramanian A, Hawes SE, et al. Detection of hypermethylation genes in women with and without cervical neoplasia. J Natl Cancer Inst. 2005;97:273-282.
27. Park JS, Dong SM, Kim HS, et al. Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. Cancer Lett. 1999;136:101-108.
28. Virmani AK, Muller C, Rathi A, et al. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res. 2001;7:584-589.
29. Lin Z, Gao M, Zhang X, et al. The hypermethylation and protein expression of p16INK4A and DNA repair gene 06-methylguanine- DNA methyltransferase in various uterine cervical lesions. J Cancer Res Clin Oncol. 2005;131:364-370.
30. Lattario F, Furtado YL, Silveira FA, et al. Evaluation of DAPK gene methylation and HPV and EBV infection of cervical cells from patients with normal cytology and colposcopy. Arch Gynecol Obstet. 2008;277:505-509.
31. Richardson H, Abrahamowicz M, Tellier PP, et al. Modifiable risk factor associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university stuDents. Cancer EpiDemiol Biomarkers Prev. 2005;14:1149-1156.
32. Syrjänen S, Shabalova IP, Petrovichev N, et al. Clearance of highrisk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New InDepenDent States of the former Soviet Union (the NES cohort study). Euro J Obstetr Gynecol and Reprodutive Biologic. 2005;119:219-227.